Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Cash Flows from Operating Activities
Net income (loss)	$ (627,264)	$ (943,024)	$ (2,041,882)	$ (2,462,799)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation			14,261	446,113
Loss (Gain) on settlement of liabilities			516,083	(67,984)
Fair value of stock issued for note modification		168,856	14,382	168,856
Amortization of debt discount			28,497	(89,876)
Changes in operating assets and liabilities:
Prepaid expenses and other assets			31,761	(17,851)
Accounts payable and accrued expenses			631,112	65,424
Accrued interest			219,910	46,517
Net cash used in operating activities			(585,876)	(1,911,600)
Cash Flows from Investing Activities:
Acquisition of mineral claims				(106,000)
Net cash provided by (used in) investing activities				(106,000)
Cash Flows from Financing Activities
Proceeds from convertible notes			55,000	2,025,000
Proceeds from convertible notes – related party			80,000
Proceeds from promissory notes			671,733	100,000
Repayment of promissory notes			(225,000)
Proceeds from warrant exercises				189,000
Net cash provided by financing activities			581,733	2,314,000
Net increase (decrease) in cash			(4,143)	296,400
Cash, beginning of period			7,376	42,582	$ 42,582
Cash, end of period	$ 3,233	$ 338,982	3,233	338,982	$ 7,376
Supplemental disclosures:
Interest paid
Supplemental disclosures of non-cash items:
Accounts payable and accrued payable exchanged for convertible note			440,129
Receivable for convertible notes
Cashless exercise of warrants